Pharma Stock Roundup: JNJ's Q1 Earnings & Sales Beat, RHHBY Sales, & Other Updates
Pharma Stock Roundup: JNJs Q1 Earnings & Sales Beat, RHHBY Sales, & Other Updates Zacks.com 2 hrs ago J&J JNJ announced strong first-quarter results, beating estimates for both earnings and sales. Roche’s RHHBY COVID-19 diagnostics tests sales boosted the top line, offsetting declines in its core drug business. The FDA granted approval to Glaxo’s GSK endometrial cancer therapy, Jemperli (dostarlimab). Recap of the Week’s Most Important Stories J&J Earnings & Sales Beat: J&J beat firs...
United States Sanofi Sarclisa Mabthera Rituxan Amgen Kyprolis Pharmacovigilance Risk Assessment Committee Us Centers For Disease
Source: msn.com